1-1 of 1
Authors: William F Symmans
Sort by
Journal Article
Neoadjuvant Talazoparib in Patients With Germline BRCA1/2 Mutation-Positive, Early-Stage Triple-Negative Breast Cancer: Results of a Phase II Study
Jennifer K Litton and others
The Oncologist, Volume 28, Issue 10, October 2023, Pages 845–855, https://doi.org/10.1093/oncolo/oyad139
Published: 15 June 2023
Advertisement
Advertisement